MENU
AEON
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
AEON Biopharma (AEON) Ownership - Who owns AEON Biopharma?
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market... Show more
Profile
Industry
N/A
Address
5 Park Plaza
Phone
+1 949 354-6499
Employees
10
Web
https://www.aeonbiopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.58M
P/E Ratio
0.00
Total Cash
10.45M
Projected Growth
N/A
Total Debt
14.6M
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
0.92
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
AEON
Capitalization
8.58M
P/E Ratio
0.00
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash
10.4M
Total Cash/Share
0.92
Total Debt
14.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-11.32M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
307.89
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
9K
Current Ratio
1.43
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-21.3M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
2009.60
Shares Held By Institutions
2.85M
Shares Outstanding - Current
11.3M
Total Liabilities
25.1M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-98.048
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
5 Park Plaza
Phone
+1 949 354-6499
Employees
10
Web
https://www.aeonbiopharma.com